{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:09:41Z","timestamp":1791050981817,"version":"4.1.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p>Purpose. The aim of the present study was to evaluate the measurement of contamination by antineoplastic drugs for safer handling of such drugs by medical workers. We investigated the relationship between the contamination level of antineoplastic drugs and the conditions of their handling.<\/jats:p>\n                  <jats:p>Methods. Air samples and wipe samples were collected from equipment in the preparation rooms of five hospitals (hospitals A\u2014E). These samples were subjected to measurement of the amounts of cyclophosphamide (CPA), fluorouracil (5FU), gemcitabine (GEM), and platinum-containing drugs (Pt). Twenty-four-hour urine samples were collected from the pharmacists who handled or audited, the antineoplastic drugs were analyzed for CPA and Pt.<\/jats:p>\n                  <jats:p>Results. Pt was detected from air samples inside BSC in hospital B. Antineoplastic drugs were detected from wipe samples of the BSC in hospitals A, B, D, and E and of other equipment in the preparation rooms in hospitals A, B, C, and D. Cyclophosphamide and 5FU were detected from wipe samples of the air-conditioner filter in hospital A, and CPA was detected from that in hospital D. Cyclophosphamide was detected from urine samples of workers in hospitals B, D, and E.<\/jats:p>\n                  <jats:p>Conclusion. The contamination level of antineoplastic drugs was suggested to be related with the amount of drugs handled, cleaning methods of the equipment, and the skill level of the technique of maintaining negative pressure inside a vial. In order to reduce the contamination and exposure to antineoplastic drugs in the hospital work environment very close to zero, comprehensive safety precautions, including adequate mixing and cleaning methods was required in addition to BSC and closed system device.<\/jats:p>","DOI":"10.1177\/1078155210380485","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T00:21:28Z","timestamp":1281486088000},"page":"29-38","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":61,"title":["Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan"],"prefix":"10.1177","volume":"17","author":[{"given":"Jin","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Environmental Health, Osaka Prefectural Institute of Public Health, Osaka, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Koda","sequence":"additional","affiliation":[{"name":"Hazard Evaluation and Epidemiology Research Group, National Institute of Occupational Safety and Health, Japan, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Nishida","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy, Kinki University School of Pharmacy, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Osaka Prefectural Institute of Public Health, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Osaka Prefectural Institute of Public Health, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Osaka Prefectural Institute of Public Health, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.56.6.354"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1539\/sangyoeisei.47.195"},{"key":"atypb3","first-page":"1","volume":"5","author":"Shirato S.","year":"1992","journal-title":"J Jpn Med Waste Res"},{"key":"atypb4","volume-title":"NIOSH ALERT preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings","author":"National Institute for Occupational Safety and Health (NIOSH).","year":"2004"},{"key":"atypb5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1078155207082350","volume":"13","author":"International Society of Oncology Pharmacy Practicioners Standards Committee.","year":"2007","journal-title":"J Oncol Pharm Pract"},{"key":"atypb6","first-page":"17","volume":"16","author":"Society of Hospital Pharmacists of Australia.","year":"1981","journal-title":"Hospital Pharm"},{"key":"atypb7","first-page":"126","volume":"34","author":"Canadian Society of Hospital Pharmacists.","year":"1981","journal-title":"Can J Hosp Pharm"},{"key":"atypb8","volume":"21","author":"Health and Safety Executive (UK).","year":"1984","journal-title":"Guidance Note MS"},{"key":"atypb9","first-page":"1193","volume":"43","author":"Yodaiken RE","year":"1986","journal-title":"Occupational Safety and Health Administration. Am J Hosp Pham"},{"key":"atypb10","volume-title":"The revised version of guideline of handling antineoplastic drugs in medical center - Manual of handling antineoplastic drugs","author":"Kitada M.","year":"2005"},{"key":"atypb11","volume-title":"Guideline for aseptic handling of injection and antineoplastic drugs","author":"Nabeshima T.","year":"2008"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1539\/joh.50.86"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1539\/joh.48.517"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1539\/joh.50.7"},{"key":"atypb15","first-page":"153","volume":"53","author":"Yoshida J.","year":"2009","journal-title":"Ann Occup Hyg"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1177\/001857879903401110"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1177\/107815520100600403"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.1.68"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1039\/B205132J"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1177\/001857870303800213"},{"key":"atypb21","first-page":"2314","volume":"60","author":"Wick C.","year":"2003","journal-title":"Am J Hosp Pharm"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050258"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1007\/BF00381477"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(93)80404-R"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5718(00)00105-4"},{"key":"atypb26","first-page":"601","volume":"44","author":"Mochizuki C.","year":"2008","journal-title":"J Jpn Soc Hosp Pharm"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070443"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-007-0284-y"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.14.1427"},{"key":"atypb30","first-page":"16","volume":"14","author":"Sessink PJ","year":"1992","journal-title":"Pharm Weekbl Sci"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155210380485","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155210380485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:14:02Z","timestamp":1777688042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155210380485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1177\/1078155210380485"],"URL":"https:\/\/doi.org\/10.1177\/1078155210380485","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}